Of Mice and Not Men: Differences between Mouse and Human Immunology

Journal of Immunology

Volumn 172, Issue 5, 2004, Pages 2731-2738

  Mestas, Javier ^a   Hughes, Christopher C W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRUTON TYROSINE KINASE; CD2 ANTIGEN; CD40 LIGAND; CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE; CYTOKINE RECEPTOR; DEFENSIN; FC RECEPTOR; FLT3 LIGAND; GAMMA INTERFERON; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN SUBCLASS; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NITRIC OXIDE SYNTHASE; PADGEM PROTEIN; PROTEIN; PROTEIN BLNK; PROTEIN KINASE ZAP 70; PROTEIN KIR; PROTEIN LAMBDA5; PROTEIN LY49; STEM CELL FACTOR; THY 1 ANTIGEN; TOLL LIKE RECEPTOR; TRANSFERRIN RECEPTOR; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; B LYMPHOCYTE; BRONCHUS; CELL DIFFERENTIATION; CELL SUBPOPULATION; CELLULAR IMMUNITY; CLINICAL TRIAL; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; ENDOTHELIUM CELL; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; LEUKOCYTE; LYMPHOCYTE; MOUSE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NATURAL SELECTION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SHORT SURVEY; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

EID: 1342303482     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.5.2731     Document Type: Short Survey

References (106)

1. Waterston, R. H., K. Lindblad-Toh, E. Birney, J. Rogers, J. F. Abril, P. Agarwal, R. Agarwala, R. Ainscough, M. Alexandersson, P. An, et al. 2002. Initial sequencing and comparative analysis of the mouse genome. Nature 420:520.
2. Shepherd, F. A., and S. S. Sridhar. 2003. Angiogenesis inhibitors under study for the treatment of lung cancer. Lung Cancer 41(Suppl. 1):S63.
3. Oehler, M. K., and R. Bicknell. 2000. The promise of anti-angiogenic cancer therapy. Br. J. Cancer. 82:749.
4. Panitch, H. S., R. L. Hirsch, A. S. Haley, and K. P. Johnson. 1987. Exacerbations of multiple sclerosis in patients treated with γ interferon. Lancet 1:893.
5. Sykes, M. 2001. Mixed chimerism and transplant tolerance. Immunity 14:417.
6. Wood, K. J. 2003. Passenger leukocytes and microchimerism: what role in tolerance induction? Transplantation 75:17S.
7. Monaco, A. P. 2003. Chimerism in organ transplantation: conflicting experiments and clinical observations. Transplantation 75:13S.
8. Haley, P. J. 2003. Species differences in the structure and function of the immune system. Toxicology 188:49.
9. Pabst, R., and I. Gehrke. 1990. Is the bronchus-associated lymphoid tissue (BALT) an integral structure of the lung in normal mammals, including humans? Am. J. Respir. Cell. Mol. Biol. 3:131.
10. Doeing, D. C., J. L. Borowicz, and E. T. Crockett. 2003. Gender dimorphism in differential peripheral blood leukocyte counts in mice using cardiac, tail, foot, and saphenous vein puncture methods. BMC Clin. Pathol. 3:3.
11. + hematopoietic stem cells capable of multilineage engrafting NOD/SCID mice express flt3: distinct flt3 and c-kit expression and response patterns on mouse and candidate human hematopoietic stem cells. Blood 102:881.
12. Ganz, T. 2003. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3:710.
13. Ouellette, A. J., and M. E. Selsted. 1996. Paneth cell defensins: endogenous peptide components of intestinal host defense. FASEB J. 10:1280.
14. Risso, A. 2000. Leukocyte antimicrobial peptides: multifunctional effector molecules of innate immunity. J. Leukocyte Biol. 68:785.
15. Janeway, C. A., Jr., and R. Medzhitov. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197.
16. Bogdan, C. 2001. Nitric oxide and the immune response. Nat. Immunol. 2:907.
17. Weinberg, J. B. 1998. Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review. Mol. Med. 4:557.
18. Schneemann, M., and G. Schoedon. 2002. Species differences in macrophage NO production are important. Nat. Immunol. 3:102.
19. Webb, J. R., S. H. Lee, and S. M. Vidal. 2002. Genetic control of innate immune responses against cytomegalovirus: MCMV meets its match. Genes Immun. 3:250.
20. Lanier, L. L. 1998. NK cell receptors. Annu. Rev. Immunol. 16:359.
21. Monteiro, R. C., and J. G. Van De Winkel. 2003. IgA Fc receptors. Annu. Rev. Immunol. 21:177.
22. Daeron, M. 1997. Fc receptor biology. Annu. Rev. Immunol. 15:203.
23. Martin, R. M., and A. M. Lew. 1998. Is IgG2a a good Th1 marker in mice? Immunol. Today. 19:49.
24. Snapper, C. M., and F. D. Finkelman. 1999. Immunoglobulin class switching. In Fundamental Immunology. W. E. Paul, ed. Lippincott-Raven, Philadelphia, p. 831.
25. Pappu, R., A. M. Cheng, B. Li, Q. Gong, C. Chiu, N. Griffin, M. White, B. P. Sleckman, and A. C. Chan. 1999. Requirement for B cell linker protein (BLNK) in B cell development. Science 286:1949.
26. Minegishi, Y., J. Rohrer, E. Coustan-Smith, H. M. Lederman, R. Pappu, D. Campana, A. C. Chan, and M. E. Conley. 1999. An essential role for BLNK in human B cell development. Science 286:1954.
27. Satterthwaite, A. B., and O. N. Witte. 2000. The role of Bruton's tyrosine kinase in B-cell development and function: a genetic perspective. Immunol. Rev. 175:120.
28. Conley, M. E., J. Rohrer, L. Rapalus, E. C. Boylin, and Y. Minegishi. 2000. Defects in early B-cell development: comparing the consequences of abnormalities in pre-BCR signaling in the human and the mouse. Immunol. Rev. 178:75.
29. Gordon, C. J., G. Grafton, P. M. Wood, M. Larche, and R. J. Armitage. 2001. Modelling the human immune response: Can mice be trusted? Curr. Opin. Pharmacol. 1:431.
30. Thomas, J. D., P. Sideras, C. I. Smith, I. Vorechovsky, V. Chapman, and W. E. Paul. 1993. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 261:355.
31. Buckley, R. H. 1999. Primary immunodeficiency diseases. In Fundamental Immunology. W. E. Paul, ed. Lippincott-Raven, Philadelphia, p. 1427.
32. Tokugawa, Y., M. Koyama, and J. Silver. 1997. A molecular basis for species differences in Thy-1 expression patterns. Mol. Immunol. 34:1263.
33. Leonard, W. J. 1999. Type 1 cytokines and interferons and their receptors. In Fundamental Immunology. W. E. Paul, ed. Lippincott-Raven, Philadelphia, p. 741.
34. Fischer, A., M. Cavazzana-Calvo, G. De Saint Basile, J. P. DeVillartay, J. P. Di Santo, C. Hivroz, F. Rieux-Laucat, and F. Le Deist. 1997. Naturally occurring primary deficiencies of the immune system. Annu. Rev. Immunol. 15:93.
35. Peschon, J. J., P. J. Morrissey, K. H. Grabstein, F. J. Ramsdell, E. Maraskovsky, B. C. Gliniak, L. S. Park, S. F. Ziegler, D. E. Williams, C. B. Ware, et al. 1994. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180:1955.
36. Roifman, C. M., J. Zhang, D. Chitayat, and N. Sharfe. 2000. A partial deficiency of interleukin-7Rα is sufficient to abrogate T-cell development and cause severe combined immunodeficiency. Blood 96:2803.
37. Elder, M. E., S. Skoda-Smith, T. A. Kadlecek, F. Wang, J. Wu, and A. Weiss. 2001. Distinct T cell developmental consequences in humans and mice expressing identical mutations in the DLAARN motif of ZAP-70. J. Immunol. 166:656.
38. Chu, D. H., N. S. van Oers, M. Malissen, J. Harris, M. Elder, and A. Weiss. 1999. Pre-T cell receptor signals are responsible for the down-regulation of Syk protein tyrosine kinase expression. J. Immunol. 163:2610.
39. Carding, S. R., and P. J. Egan. 2002. γδ T cells: functional plasticity and heterogeneity. Nat. Rev. Immunol. 2:336.
40. Elbe, A., C. A. Foster, and G. Stingl. 1996. T-cell receptor αβ and γδ T cells in rat and human skin-are they equivalent?. Semin. Immunol. 8:341.
41. Dutronc, Y., and S. A. Porcelli. 2002. The CD1 family and T cell recognition of lipid antigens. Tissue Antigens. 60:337.
42. Kaufmann, S. H. 2001. How can immunology contribute to the control of tuberculosis? Nat. Rev. Immunol. 1:20.
43. Flynn, J. L., and J. Chan. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93.
44. Farrar, J. D., J. D. Smith, T. L. Murphy, S. Leung, G. R. Stark, and K. M. Murphy. 2000. Selective loss of type I interferon-induced STAT4 activation caused by a minisatellite insertion in mouse Stat2. Nat. Immunol. 1:65.
45. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348.
46. Del Prete, G. F., M. De Carli, C. Mastromauro, R. Biagiotti, D. Macchia, P. Falagiani, M. Ricci, and S. Romagnani. 1991. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J. Clin. Invest. 88:346.
47. Romagnani, S. 1991. Human TH1 and TH2 subsets: doubt no more. Immunol. Today. 12:256.
48. Allen, J. E., and R. M. Maizels. 1997. Th1-Th2: reliable paradigm or dangerous dogma? Immunol. Today 18:387.
49. Gor, D. O., N. R. Rose, and N. S. Greenspan. 2003. TH1-TH2: a procrustean paradigm. Nat. Immunol. 4:503.
50. Murphy, K. M. 2003. In search of the CTD. Nat. Immunol. 4:645.
51. Del Prete, G., M. De Carli, F. Almerigogna, M. G. Giudizi, R. Biagiotti, and S. Romagnani. 1993. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 150:353.
52. Hagan, P. 1993. IgE and protective immunity to helminth infections. Parasite Immunol. 15:1.
53. + T cell response to Schistosoma mansoni. Exp. Parasitol. 73:110.
54. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233.
55. McAdam, A. J., R. J. Greenwald, M. A. Levin, T. Chernova, N. Malenkovich, V. Ling, G. J. Freeman, and A. H. Sharpe. 2001. ICOS is critical for CD40-mediated antibody class switching. Nature 409:102.
56. Tafuri, A., A. Shahinian, F. Bladt, S. K. Yoshinaga, M. Jordana, A. Wakeham, L. M. Boucher, D. Bouchard, V. S. Chan, G. Duncan, et al. 2001. ICOS is essential for effective T-helper-cell responses. Nature 409:105.
57. Grimbacher, B., A. Hutloff, M. Schlesier, E. Glocker, K. Warnatz, R. Drager, H. Eibel, B. Fischer, A. A. Schaffer, H. W. Mages, et al. 2003. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat. Immunol. 4:261.
58. Pan, J., L. Xia, and R. P. McEver. 1998. Comparison of promoters for the murine and human P-selectin genes suggests species-specific and conserved mechanisms for transcriptional regulation in endothelial cells. J. Biol. Chem. 273:10058.
59. Barnaba, V., C. Watts, M. de Boer, P. Lane, and A. Lanzavecchia. 1994. Professional presentation of antigen by activated human T cells. Eur. J. Immunol. 24:71.
60. + T cell alloactivation. J. Exp. Med. 190:555.
61. Taams, L. S., W. van Eden, and M. H. Wauben. 1999. Antigen presentation by T cells versus professional antigen-presenting cells (APC): differential consequences for T cell activation and subsequent T cell-APC interactions. Eur. J. Immunol. 29:1543.
62. Tibbetts, M. D., L. Zheng, and M. J. Lenardo. 2003. The death effector domain protein family: regulators of cellular homeostasis. Nat. Immunol. 4:404.
63. Chun, H. J., L. Zheng, M. Ahmad, J. Wang, C. K. Speirs, R. M. Siegel, J. K. Dale, J. Puck, J. Davis, C. G. Hall, et al. 2002. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419:395.
64. + channel in effector memory T cells as new target for MS. J. Clin. Invest. 111:1703.
65. Koo, G. C., J. T. Blake, A. Talento, M. Nguyen, S. Lin, A. Sirotina, K. Shah, K. Mulvany, D. Hora, Jr., P. Cunningham, et al. 1997. Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo. J. Immunol. 158:5120.
66. Olson, T. S., and K. Ley. 2002. Chemokines and chemokine receptors in leukocyte trafficking. Am. J. Physiol. 283:R7.
67. Zlotnik, A., and O. Yoshie. 2000. Chemokines: a new classification system and their role in immunity. Immunity. 12:121.
68. Pedotti, R., J. J. De Voss, L. Steinman, and S. J. Galli. 2003. Involvement of both "allergic" and "autoimmune" mechanisms in EAE, MS and other autoimmune diseases. Trends Immunol. 24:479.
69. Lublin, F. D., R. L. Knobler, B. Kalman, M. Goldhaber, J. Marini, M. Perrault, C. D'Imperio, J. Joseph, S. S. Alkan, and R. Korngold. 1993. Monoclonal anti-γ interferon antibodies enhance experimental allergic encephalomyelitis. Autoimmunity 16:267.
70. Heremans, H., C. Dillen, M. Groenen, E. Martens, and A. Billiau. 1996. Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon-γ. Eur. J. Immunol. 26:2393.
71. 1 integrin. Nature 356:63.
72. Miller, D. H., O. A. Khan, W. A. Sheremata, L. D. Blumhardt, G. P. Rice, M. A. Libonati, A. J. Willmer-Hulme, C. M. Dalton, K. A. Miszkiel, and P. W. O'Connor. 2003. A controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 348:15.
73. Dumonde, D. C., M. S. Pulley, F. J. Paradinas, B. M. Southcott, D. O'Connell, M. R. Robinson, F. den Hollander, and A. H. Schuurs. 1982. Histological features of skin reactions to human lymphoid cell line lymphokine in patients with advanced cancer. J. Pathol. 138:289.
74. Crowle, A. J. 1975. Delayed hypersensitivity in the mouse. Adv. Immunol. 20:197.
75. Pober, J. S., M. S. Kluger, and J. S. Schechner. 2001. Human endothelial cell presentation of antigen and the homing of memory/effector T cells to skin. Ann. NY Acad. Sci. 941:12.
76. + memory T cells. Cell Immunol. 194:150.
77. Mestas, J., and C. C. Hughes. 2001. Endothelial cell costimulation of T cell activation through CD58-CD2 interactions involves lipid raft aggregation. J. Immunol. 167:4378.
78. + T lymphocytes in a B7-dependent fashion. J. Immunol. 169:6154.
79. Freiras, R. 1999. Lymphatic system. In Nanomedicine, Volume I: Basic Capabilities. Landes Bioscience, Georgetown, TX, p. 68.
80. Choo, J. K., J. D. Seebach, V. Nickeleit, A. Shimizu, H. Lei, D. H. Sachs, and J. C. Madsen. 1997. Species differences in the expression of major histocompatibility complex class II antigens on coronary artery endothelium: implications for cell-mediated xenoreactivity. Transplantation 64:1315.
81. Hughes, C. C., C. O. Savage, and J. S. Pober. 1990. Endothelial cells augment T cell interleukin 2 production by a contact-dependent mechanism involving CD2/LFA-3 interaction. J. Exp. Med. 171:1453.
82. van der Merwe, P. A. 1999. A subtle role for CD2 in T cell antigen recognition. J. Exp. Med 190:1371.
83. Karmann, K., C. C. Hughes, J. Schechner, W. C. Fanslow, and J. S. Pober. 1995. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc. Natl. Acad. Sci. USA 92:4342.
84. Ensminger, S. M., B. M. Spriewald, T. Fischlein, M. Weyand, P. J. Morris, and K. J. Wood. 2003. Mouse endothelial CD40 expression does not play a role during the development of transplant arteriosclerosis. Endothelium 10:111.
85. McDade, T. W., and C. M. Worthman. 1999. Evolutionary process and the ecology of human immune function. Am. J. Human Biol. 11:705.
86. Martin, A. M., J. K. Kulski, C. Witt, P. Pontarotti, and F. T. Christiansen. 2002. Leukocyte Ig-like receptor complex (LRC) in mice and men. Trends Immunol. 23:81.
87. Gurtner, G. C., V. Davis, H. Li, M. J. McCoy, A. Sharpe, and M. I. Cybulsky. 1995. Targeted disruption of the murine VCAM1 gene: essential role of VCAM-1 in chorioallantoic fusion and placentation. Genes Dev. 9:1.
88. Rehli, M. 2002. Of mice and men: species variations of Toll-like receptor expression. Trends Immunol. 23:375.
89. Heinz, S., V. Haehnel, M. Karaghiosoff, L. Schwarzfischer, M. Muller, S. W. Krause, and M. Rehli. 2003. Species-specific regulation of Toll-like receptor 3 genes in men and mice. J. Biol. Chem. 278:21502.
90. Lund, J., A. Sato, S. Akira, R. Medzhitov, and A. Iwasaki. 2003. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198:513.
91. Trevani, A. S., A. Chorny, G. Salamone, M. Vermeulen, R. Gamberale, J. Schettini, S. Raiden, and J. Geffner. 2003. Bacterial DNA activates human neutrophils by a CpG-independent pathway. Eur. J. Immunol. 33:3164.
92. Varki, A. 2001. Loss of N-glycolylneuraminic acid in humans: mechanisms, consequences, and implications for hominid evolution. Am. J. Phys. Anthropol. 33(Suppl.):54.
93. Brinkman-Van der Linden, E. C., T. Angata, S. A. Reynolds, L. D. Powell, S. M. Hedrick, and A. Varki. 2003. CD33/Siglec-3 binding specificity, expression pattern, and consequences of gene deletion in mice. Mol. Cell Biol. 23:4199.
94. Cunliffe, R. N., F. R. Rose, J. Keyte, L. Abberley, W. C. Chan, and Y. R. Mahida. 2001. Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some villous epithelial cells and by metaplastic Paneth cells in the colon in inflammatory bowel disease. Gut 48:176.
95. Ghosh, D., E. Porter, B. Shen, S. K. Lee, D. Wilk, J. Drazba, S. P. Yadav, J. W. Crabb, T. Ganz, and C. L. Bevins. 2002. Paneth cell trypsin is the processing enzyme for human defensin-5. Nat. Immunol. 3:583.
96. Crocker, P. R., W. A. Jefferies, S. J. Clark, L. P. Chung, and S. Gordon, 1987. Species heterogeneity in macrophage expression of the CD4 antigen. J. Exp. Med. 166:613.
97. Kaufmann, S. H. 1996. γ/δ and other unconventional T lymphocytes: what do they see and what do they do? Proc. Natl. Acad. Sci. USA 93:2272.
98. Raulet, D. H. 2003. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 3:781.
99. Gao, J. L., and P. M. Murphy. 1993. Species and subtype variants of the N-formyl peptide chemotactic receptor reveal multiple important functional domains. J. Biol. Chem. 268:25395.
100. Zemlin, M., M. Klinger, J. Link, C. Zemlin, K. Bauer, J. A. Engler, H. W. Schroeder, Jr., and P. M. Kirkham. 2003. Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures. J. Mol. Biol. 334:733.
101. Chapoval, A. I., J. Ni, J. S. Lau, R. A. Wilcox, D. B. Flies, D. Liu, H. Dong, G. L. Sica, G. Zhu, K. Tamada, and L. Chen. 2001. B7-H3: a costimulatory molecule for T cell activation and IFN-γ production. Nat. Immunol. 2:269.
102. Suh, W. K., B. U. Gajewska, H. Okada, M. A. Gronski, E. M. Bertram, W. Dawicki, G. S. Duncan, J. Bukczynski, S. Plyte, A. Elia, et al. 2003. The B7 family member
103. Geijtenbeek, T. B., R. Torensma, S. J. van Vliet, G. C. van Duijnhoven, G. J. Adema, Y. van Kooyk, and C. G. Figdor. 2000. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100:575.
104. van Kooyk, Y., and T. B. Geijtenbeek. 2002. A novel adhesion pathway that regulates dendritic cell trafficking and T cell interactions. Immunol. Rev. 186:47.
105. Crommie, D., and S. D. Rosen. 1995. Biosynthesis of GlyCAM-1, a mucin-like ligand for L-selectin. J. Biol. Chem. 270:22614.
106. Correa, I., T. Plunkett, A. Vlad, A. Mungul, J. Candelora-Kettel, J. M. Burchell, J. Taylor-Papadimitriou, and O. J. Finn. 2003. Form and pattern of MUC1 expression on T cells activated in vivo ot in vitro suggests a function in T-cell migration. Immunology 108:32.